- Molecular genetic data favoring a sequential clonal transformation of a large B cell lymphoma into an anaplastic large T cell lymphoma, ALK-negative2015 | Faculty of Medicine in Pilsen
- Intravascular Large B-Cell Lymphoma Presenting as Cutaneous Panniculitis2003 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Diffuse large B cell lymphomas (DLBCL) analysis of the heterogeneous group by means of immunohistochemistry, PCR and FISHPublication without faculty affiliation
- Primary diffuse large B-cell lymphoma of the parietal bone2021 | Third Faculty of Medicine
- The histomorphologic spectrum of primary cutaneous diffuse large B-cell lymphoma: A study of 79 cases2011 | Faculty of Medicine in Pilsen
- Diffuse Large B- cell Lymphoma - Modern Diagnostics and Molecularly Targeted Treatment2015 | First Faculty of Medicine
- Systemic anaplastic large T-cell lymphoma (ALCL), the current state of knowledge and new treatment possibilities2013 | Publication without faculty affiliation
- BRD4 inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosis2023 | First Faculty of Medicine
- Anti-CD38 Therapy with Daratumumab for Relapsed/Refractory CD20-Negative Diffuse Large B-Cell Lymphoma2020 | First Faculty of Medicine, Second Faculty of Medicine
- Distinguishing of primary mediastinal B-cell lymphoma and diffuse large B-cell lymphoma using real-time quantitative polymerase chain reaction2010 | First Faculty of Medicine
- Extranodal diffuse large B-cell lymphoma in the orofacial region (5 case reports)Publication without faculty affiliation
- Unusual clinicopathological presentation of primary cutaneous diffuse large B-cell lymphoma, leg type, with multiple nodules and widespread garland-like lesions2009 | Central Library of Charles University
- Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma2017 | Publication without faculty affiliation
- Diffuse large B-cell lymphoma, clinical characterisatic and treatment options - data from register of Czech lymphoma group2004 | Publication without faculty affiliation
- Diffuse Large B-Cell Lymphoma (DLBCL): Early Patient Management and Emerging Treatment Options2022 | First Faculty of Medicine
- Unusual clinicopathological presentation of primary cutaneous diffuse large B-cell lymphoma, leg type, with multiple nodules and widespread garland-like lesions2009 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Diffuse large B-cell lymphoma in a patient with hyper-IgE syndrome: successful treatment with risk-adapted rituximab-based immunochemotherapy2010 | Faculty of Medicine in Hradec Králové
- Diffuse large B cell lymphomas in flow cytometry +1Publication without faculty affiliation
- The interval between progression and therapy initiation is the key prognostic parameter in relapsing diffuse large B cell lymphoma: analysis from the Czech Lymphoma Study Group database (NIHIL)2020 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
- A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA2020 | First Faculty of Medicine
- Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20(+) Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma2012 | First Faculty of Medicine
- Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma2019 | Faculty of Medicine in Hradec Králové
- ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)2013 | First Faculty of Medicine
- Distinguishing of primary mediastinal B-cell lymphoma and diffuse large B-cell lymphoma using real-time quantitative polymerase chain reactionPublication without faculty affiliation
- Distinguishing of primary mediastinal B-cell lymphoma and diffuse large B-cell lymphoma using real-time quantitative polymerase chain reaction2010 | Second Faculty of Medicine
- Can Cutaneous Low-Grade B-cell Lymphoma Transform Into Primary Cutaneous Diffuse Large B-cell Lymphoma? An Immunohistochemical Study of 82 cases2014 | Faculty of Medicine in Pilsen
- Diffuse Large B-cell Lymphoma of Gingiva2007 | Faculty of Medicine in Hradec Králové
- Diffuse large B cell lymphomas: subclassification by means pf clasical and molecular diagnostic methods +1Publication without faculty affiliation